Ignite Creation Date:
2025-12-24 @ 12:24 PM
Ignite Modification Date:
2026-03-12 @ 3:05 PM
Study NCT ID:
NCT00887861
Status:
COMPLETED
Last Update Posted:
2017-03-21
First Post:
2009-04-23
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy of BGG492 in Individuals With Refractory Partial Seizures Undergoing Inpatient Evaluation for Epilepsy Surgery
Sponsor:
Novartis
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CBGG492A2202
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None